Topeka, KS, United States of America

Peter A Parks

This inventor holds 12 USPTO granted patents. Top assignees: Eastman-Kodak Company, The Mclean Hospital Corporation. Active years: 2001-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter A Parks. Retrieved from https://idiyas.com/inventor/peter-a-parks

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 66.7

Average Co-Inventor Count = 4.2

ph-index = 12

Forward Citations = 556(Granted Patents)


Company Filing History:


Years Active: 2001-2006

Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Peter A Parks

Introduction

Peter A Parks is a notable inventor based in Topeka, Kansas. He has made significant contributions to the field of medical technology, particularly in the diagnosis and treatment of Attention Deficit Hyperactivity Disorder (ADHD). With a total of 12 patents to his name, Parks has developed innovative methods that enhance the understanding and management of ADHD.

Latest Patents

Among his latest patents is a method and apparatus for determining ADHD medication dosage and monitoring its effects. This method involves sampling the peripheral skin temperature of an individual during a sensory deprived state to derive data that indicates the level of ADHD manifestation. The effectiveness of the medication is calculated by comparing the data to predetermined threshold values. Another significant patent is a technique for diagnosing ADHD using complementary tests. This method includes sampling peripheral skin temperature data from subjects known to have ADHD and those who do not, ultimately determining threshold values that effectively identify ADHD.

Career Highlights

Peter A Parks has worked with prominent organizations such as Eastman Kodak Company and The McLean Hospital Corporation. His experience in these institutions has contributed to his expertise in developing innovative solutions for ADHD.

Collaborations

Parks has collaborated with notable individuals in his field, including Richard N Blazey and David Lynn Patton. These collaborations have likely enriched his research and development efforts.

Conclusion

Peter A Parks stands out as an influential inventor whose work has the potential to significantly impact the diagnosis and treatment of ADHD. His innovative patents reflect a commitment to improving the lives of individuals affected by this condition.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…